GlassScriptPhysician profile
Ryan Woldahl
NPI 1639809981
$5,391.26
in general payments reported to CMS, 2019-2025
22 companies · $545 in 2025
The $545 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $569 · 2023: $516 · 2024: $3,762 · 2025: $545.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,699 · Travel and Lodging: $1,124.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,698.54 |
| Travel and Lodging | $1,124.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,498.24 | 2022-2024 | Ortholoc 3di, Ortholoc 2 Lapifuse, Variax |
| Paragon 28, INC. | $426.88 | 2023-2025 | Portfolio, Mtp, Precision Mis Bunion |
| Kerecis Limited | $352.24 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Bioventus LLC | $296.43 | 2022-2024 | Exogen Ultrasound Bone Healing System |
| Depuy Synthes Sales INC. | $238.10 | 2024 | N/A |
| Solventum Corporation | $192.66 | 2024-2025 | Prevena, V.A.C.Instill, Activ.A.C. |
| Horizon Therapeutics Plc | $178.58 | 2022 | |
| Nevro Corp. | $170.89 | 2023 | Senza |
| Melinta Therapeutics, LLC | $132.81 | 2022 | |
| Paratek Pharmaceuticals, INC. | $124.74 | 2024 | Nuzyra |
| Lightbody Medical Technologies INC | $114.53 | 2024 | |
| Urgo Medical North America, LLC | $113.40 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Treace Medical Concepts, INC. | $102.84 | 2025 | |
| Smith+Nephew, INC. | $76.97 | 2023 | Acticoat 4" X 4", Allevyn Heel 10.5cm X 13.5cm Ctn 5, Iodosorb Ointment 40g USA |
| Amgen INC. | $66.85 | 2024 | Krystexxa |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $61.80 | 2024 | Zynrelef |
| Linvatec Corporation | $54.28 | 2025 | Biobrace 23mm |
| Zak Ortho | $52.14 | 2024 | |
| Biopro, INC. | $51.85 | 2025 | Hemi Toe |
| Medwest Associates | $49.47 | 2023 | |
| Integra Lifesciences Corporation | $26.23 | 2023 | Integra, Surgimend, Omnigraft |
| Accufix Surgical INC. | $9.33 | 2023 | Accu-Joint |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Woldahl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.